Dullaart R P, Gansevoort R T, Dikkeschei B D, de Zeeuw D, de Jong P E, Van Tol A
Department of Endocrinology, State University Hospital Groningen, The Netherlands.
Kidney Int. 1993 Jul;44(1):91-7. doi: 10.1038/ki.1993.217.
Lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) are key factors in the esterification of free cholesterol, and the distribution of cholesteryl ester among lipoproteins in plasma. Alterations in these processes may play a role in the lipoprotein abnormalities associated with glomerular proteinuria. The activities of LCAT and CETP were measured using excess exogenous substrate assays in nine patients with nephrotic-range proteinuria and in 18 matched controls. The proteinuria-lowering effect of four weeks of angiotensin converting enzyme (ACE) inhibition with enalapril was also studied. Plasma very low lipoprotein and low density lipoprotein (VLDL and LDL) cholesterol, triacylglycerol and apolipoprotein B levels were significantly elevated in the patients compared with controls. High density lipoprotein (HDL) total cholesterol, free cholesterol, cholesteryl ester and the free cholesterol/cholesteryl ester ratio in HDL were lower. Total plasma apolipoprotein A1 was normal. Plasma LCAT and CETP activities were elevated in the patients by 30% (P < 0.01) and by 39% (P < 0.01), respectively, and were both inversely related to serum albumin. VLDL and LDL cholesterol levels were positively related to LCAT and CETP activities, whereas the HDL free cholesterol content was inversely related to LCAT activity. ACE inhibition resulted in a 40% reduction of proteinuria, a partial normalization of LCAT activity, and a decrease in VLDL and LDL cholesterol. In conclusion, elevated activities of LCAT and CETP may provide a mechanism that contributes to the low proportion of cholesterol in HDL relative to that in VLDL and LDL, as well as to the compositional changes of HDL seen in glomerular proteinuria.(ABSTRACT TRUNCATED AT 250 WORDS)
卵磷脂胆固醇酰基转移酶(LCAT)和胆固醇酯转运蛋白(CETP)是游离胆固醇酯化以及血浆中胆固醇酯在脂蛋白间分布的关键因素。这些过程的改变可能在与肾小球蛋白尿相关的脂蛋白异常中起作用。采用过量外源性底物分析法测定了9例肾病范围蛋白尿患者和18例匹配对照者的LCAT和CETP活性。还研究了用依那普利进行四周血管紧张素转换酶(ACE)抑制的降蛋白尿作用。与对照组相比,患者的血浆极低密度脂蛋白和低密度脂蛋白(VLDL和LDL)胆固醇、三酰甘油和载脂蛋白B水平显著升高。高密度脂蛋白(HDL)总胆固醇、游离胆固醇、胆固醇酯以及HDL中的游离胆固醇/胆固醇酯比值较低。血浆总载脂蛋白A1正常。患者血浆LCAT和CETP活性分别升高30%(P<0.01)和39%(P<0.01),且均与血清白蛋白呈负相关。VLDL和LDL胆固醇水平与LCAT和CETP活性呈正相关,而HDL游离胆固醇含量与LCAT活性呈负相关。ACE抑制使蛋白尿减少40%,LCAT活性部分恢复正常,VLDL和LDL胆固醇降低。总之,LCAT和CETP活性升高可能是导致HDL中胆固醇相对于VLDL和LDL中胆固醇比例较低以及肾小球蛋白尿中HDL成分改变的一种机制。(摘要截短于250字)